Side-by-side comparison of AI visibility scores, market position, and capabilities
New York specialty ingredients (NYSE: IFF) at $11.48B 2024 net sales, EBITDA +16%; flavors/fragrances + N&B health/biosciences ($26B 2021 acquisition), 2025 guidance 1-4% growth competing with Givaudan and dsm-firmenich.
International Flavors & Fragrances Inc. (IFF) is a New York City, New York-based global specialty ingredients company — publicly traded on the New York Stock Exchange (NYSE: IFF) as an S&P 500 Materials component — creating and manufacturing flavors, fragrances, enzymes, probiotics, food ingredients, cosmetic actives, and pharmaceutical excipients for consumer goods companies, food manufacturers, beverage companies, and pharmaceutical firms through approximately 20,000 employees in 110 countries. In fiscal year 2024, IFF reported net sales of $11.48 billion and adjusted operating EBITDA growth of 16% to $2.21 billion, demonstrating improved profitability following the challenging integration of the DuPont Nutrition & Biosciences business (acquired 2021 for ~$26 billion in the largest transaction in IFF's history). For 2025, IFF guided 1-4% comparable currency-neutral sales growth, with continued margin improvement as the integration synergies are realized. CEO Jon Erik Fyrwald leads the company through its integration and portfolio optimization phase. IFF operates across four segments: Nourish (flavors, functional ingredients, proteins, food and beverage innovation), Scent (fine fragrances, consumer fragrances, cosmetic actives), Health & Biosciences (enzymes, microbiome, probiotics, animal nutrition), and Pharma Solutions (pharmaceutical excipients and delivery systems) — serving every major category of consumer products from food and beverages to personal care, household products, and medicine.
€75.9B revenue FY2024 (+3% comparable); Q3 FY2025 €19.4B (+5% comparable); 3-7% comparable growth expected FY2025; automation business recovering Q3; manufacturing automation leader
Siemens is a German technology and industrial conglomerate founded in 1847 by Werner von Siemens, one of the oldest and most broadly diversified technology companies in the world. Today the company's focus is concentrated in two high-growth segments: Digital Industries, which provides automation, industrial software, and manufacturing execution systems; and Smart Infrastructure, which delivers grid technology, building automation, and electrification solutions. Siemens' core technology platform, the Siemens Xcelerator open digital business ecosystem, connects hardware, software, and services into an integrated industrial AI and automation layer.\n\nSiemens' product and solutions portfolio spans factory automation (PLCs, drives, robots), simulation and digital twin software (through Siemens EDA and Siemens Opcenter), building management systems, power grid components, and electrification infrastructure. Its industrial software business — including the NX CAD/CAM suite, Teamcenter PLM, and MindSphere industrial IoT platform — serves aerospace, automotive, electronics, and energy companies managing the complexity of modern product development and manufacturing operations.\n\nSiemens generated €75.9B in revenue in FY2024, a 3% increase, and reported €19.4B in Q3 FY2025 revenue, up 5%. The company has positioned itself as a leader in the industrial AI and automation megatrend, investing heavily in AI-augmented manufacturing tools and smart grid technology needed to support the global energy transition. With a $100B+ market capitalization and deep relationships across global industry, Siemens is well positioned to capture the digitization and electrification capex cycle accelerating through the late 2020s.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.